WallStreetZenWallStreetZen

NASDAQ: MTSR
Metsera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MTSR

Based on 2 analysts offering 12 month price targets for Metsera Inc

Min Forecast
$38.00+63.09%
Avg Forecast
$47.00+101.72%
Max Forecast
$56.00+140.34%

Should I buy or sell MTSR stock?

Based on 2 analysts offering ratings for Metsera Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MTSR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MTSR as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their MTSR stock forecasts and price targets.

MTSR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-25
lockedlocked$00.00+00.00%2025-02-25

1 of 1

Forecast return on equity

Is MTSR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is MTSR forecast to generate an efficient return on assets?

Company
-79.2%
Industry
985.04%
MTSR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MTSR earnings per share forecast

What is MTSR's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$3.39
Avg 2 year Forecast
-$3.40

MTSR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MTSR$23.30$47.00+101.72%Strong Buy
VCYT$31.38$42.00+33.84%Buy
ACAD$14.43$23.86+65.33%Buy
DNLI$16.50$39.36+138.57%Strong Buy
MLTX$40.18$75.80+88.65%Buy
View Top Biotech Stocks

Metsera Stock Forecast FAQ

Is Metsera Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MTSR) stock is to Strong Buy MTSR stock.

Out of 2 analysts, 2 (100%) are recommending MTSR as a Strong Buy, 0 (0%) are recommending MTSR as a Buy, 0 (0%) are recommending MTSR as a Hold, 0 (0%) are recommending MTSR as a Sell, and 0 (0%) are recommending MTSR as a Strong Sell.

If you're new to stock investing, here's how to buy Metsera stock.

What is MTSR's earnings growth forecast for 2025-2026?

(NASDAQ: MTSR) Metsera's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 31.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.53%.

Metsera's earnings in 2025 is -$209,127,000.On average, 2 Wall Street analysts forecast MTSR's earnings for 2025 to be -$355,594,991, with the lowest MTSR earnings forecast at -$376,079,784, and the highest MTSR earnings forecast at -$335,110,199.

In 2026, MTSR is forecast to generate -$357,170,745 in earnings, with the lowest earnings forecast at -$357,170,745 and the highest earnings forecast at -$357,170,745.

What is MTSR's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: MTSR) forecast ROE is N/A, which is considered weak.

What is MTSR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MTSR price target, the average MTSR price target is $47.00, with the highest MTSR stock price forecast at $56.00 and the lowest MTSR stock price forecast at $38.00.

On average, Wall Street analysts predict that Metsera's share price could reach $47.00 by Feb 25, 2026. The average Metsera stock price prediction forecasts a potential upside of 101.72% from the current MTSR share price of $23.30.

What is MTSR's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: MTSR) Metsera's current Earnings Per Share (EPS) is -$14.49. On average, analysts forecast that MTSR's EPS will be -$3.39 for 2025, with the lowest EPS forecast at -$3.58, and the highest EPS forecast at -$3.19. In 2026, MTSR's EPS is forecast to hit -$3.40 (min: -$3.40, max: -$3.40).

What is MTSR's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: MTSR) forecast ROA is -79.2%, which is lower than the forecast US Biotechnology industry average of 985.04%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.